Stock TMCI TREACE MEDICAL CONCEPTS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
5.91 USD -3.27% Intraday chart for Treace Medical Concepts, Inc. +0.51% -53.65%
May. 29 Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing MT
May. 17 North American Morning Briefing : The "Everything -2- DJ

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Treace to Present at Truist Securities MedTech Conference
AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
BU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Treace Medical Concepts: Q1 Earnings Snapshot
AQ
Treace Medical Concepts Reports First Quarter 2024 Financial Results
AQ
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
AQ
Treace to Present at Bank of America Health Care Conference
GL
Treace Announces First Annual National Bunion Day
GL
Treace to Report First Quarter 2024 Financial Results
GL
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
GL
Treace Medical Concepts: Q4 Earnings Snapshot
AQ
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
GL
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
GL
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
GL
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
GL
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
AQ
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TMCI Stock
  4. News Treace Medical Concepts, Inc.
  5. Press Releases